Skip to main content

Advertisement

Table 2 Triacylglycerols and cholesterol concentrations in major lipoprotein subfractions in SHR, SHR-Dca+/− and SHR-Dca−/− male rats

From: Heterozygous connexin 50 mutation affects metabolic syndrome attributes in spontaneously hypertensive rat

Trait (mg/dl) SHR SHR-Dca+/− SHR-Dca−/− p-value
Total TG 34.5 ± 2.4 51.3 ± 7.2*, a 34.4 ± 2.5 0.026
Chylomicron TG 6.20 ± 0.87 10.53 ± 1.80*, a 5.78 ± 0.79 0.030
VLDL-TG 15.7 ± 1.3 26.8 ± 4.9*, a 16.0 ± 1.4 0.025
LDL-TG 9.63 ± 0.55 9.98 ± 0.76 9.84 ± 0.32 0.91
HDL-TG 2.89 ± 0.22 3.19 ± 0.21 2.84 ± 0.13 0.42
Total C 81.4 ± 5.2 58.0 ± 3.2† 70.2 ± 5.7 0.016
Chylomicron C 0.70 ± 0.07 0.83 ± 0.09 0.63 ± 0.06 0.19
VLDL-C 2.64 ± 0.12 2.67 ± 0.30 2.19 ± 0.15 0.22
LDL-C 26.2 ± 3.0 13.6 ± 1.3† 18.7 ± 3.0 0.015
HDL-C 51.8 ± 2.2 40.9 ± 2.3†, a 48.6 ± 2.7 0.020
  1. Triacylglycerols (TG) and cholesterol (C) concentrations in major lipoprotein subfractions (chylomicron, VLDL very low-density lipoprotein, LDL low-density lipoprotein, HDL high-density lipoprotein) in SHR, SHR-Dca+/− and SHR-Dca−/− male rats. Data are shown as mean ± SEM. The significance levels of one-way ANOVA for STRAIN as a major factor are shown in last column; significant values are italicized. * p < 0.05 and † p < 0.01 for pair-wise comparisons (post-hoc Tukey’s HSD test) between SHR-Dca−/− or SHR-Dca+/− strains vs. SHR. a p < 0.05 for pair-wise comparisons between SHR-Dca−/− and SHR-Dca+/− strains. * p < 0.05 vs. SHR.p < 0.01 vs. SHR. a p < 0.05 vs. SHR-Dca−/−